European Regulatory Round-Up: EMA And The UK Heed The Calls Of Industry; France Is Otherwise Occupied
Executive Summary
The European Medicines Agency follows through on its transparency initiative with comprehensive list of products under review and also reduces pharmacovigilence data reporting requirements.
You may also be interested in...
Japan Pharma Gearing Up For Battle In Reimbursement Talks As Tax Landscape Shifts
Increased consumption tax and tax credits for R&D offer a new playing field as 2014 price revision talks take shape.
Japan Pharma Gearing Up For Battle In Reimbursement Talks As Tax Landscape Shifts
Increased consumption tax and tax credits for R&D offer a new playing field as 2014 price revision talks take shape.
European Regulatory Round-Up: EMA And The UK Heed The Calls Of Industry; France Is Otherwise Occupied
The European Medicines Agency follows through on its transparency initiative with comprehensive list of products under review and also reduces pharmacovigilence data reporting requirements.